Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of mdr-tb and xdr-tb in china: A prospective multicentre study

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 2, 2015, Pages 456-462

  Huang, Zikun ^a   Qin, Cheng ^a   Du, Jinghui ^b   Luo, Qing ^a   Wang, Yaoxing ^c   Zhang, Wang ^d   Zhang, Xi ^e   Xiong, Guoliang ^f   Chen, Jie ^a   Xu, Xiaomeng ^a   Li, Weiting ^a   Li, Junming ^a  

^a NANCHANG UNIVERSITY   (China)

^b FIRST TEACHING HOSPITAL OF TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^d THE UNIVERSITY OF HONG KONG SHENZHEN HOSPITAL   (China)

^e KUNMING MEDICAL UNIVERSITY   (China)

^f DEPARTMENT OF HEALTH   (Hong Kong)

Author keywords

Diagnosis; Drug resistance; Second line drugs; Tuberculosis

Indexed keywords

CAPREOMYCIN; ISONIAZID; ISONIAZID PLUS RIFAMPICIN; KANAMYCIN; OFLOXACIN; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; ASSAY; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM DETECTION; CHINA; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG SUSCEPTIBILITY ASSAY; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FALSE POSITIVE RESULT; FEMALE; HOSPITAL PATIENT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MULTICENTER STUDY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIAL GROWTH INDICATOR TUBE CULTURE; MYCOBACTERIUM TUBERCULOSIS; OUTPATIENT; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SPUTUM ANALYSIS; SPUTUM SMEAR; SYSTEMATIC REVIEW; CLINICAL TRIAL; DRUG EFFECTS; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PROCEDURES; REPRODUCIBILITY; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ADULT; ANTITUBERCULAR AGENTS; CHINA; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84922470506     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku384     Document Type: Article

References (25)

1. WHO. Multidrug and Extensively Drug-Resistant TB (M/XDR-TB): 2010 Global Report on Surveillance and Response. http://whqlibdoc.who.int/ publications/2010/9789241599191_eng.pdf.
2. WHO. Global Tuberculosis Report 2013. http://www.who.int/tb/ publications/global_report/gtbr13_main_text.pdf?ua=1.
3. Zhao Y, Xu S,Wang L et al. National survey of drug-resistant tuberculosis in China. N Engl J Med 2012; 366: 2161-70.
4. Zhao M, Li X, Xu P et al. Transmission of MDR and XDR tuberculosis in Shanghai, China. PLoS One 2009; 4: e4370.
5. WHO. Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs. Geneva, Switzerland, 2008. http://whqlibdoc.who. int/hq/2008/WHO_HTM_TB_2008.392_eng.pdf?ua=1.
6. Rodrigues C, Jani J, Shenai S et al. Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 System. Int J Tuberc Lung Dis 2008; 12: 1449-55.
7. Liu Q, Luo T, Li J et al. Triplex real-time PCR melting curve analysis for detecting Mycobacterium tuberculosis mutations associated with resistance to second-line drugs in a single reaction. J Antimicrob Chemother 2013; 68: 1097-103.
8. Caviedes L, Lee TS, Gilman RH et al. Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru. J Clin Microbiol 2000; 38: 1203-8.
9. Moore DA, Evans CA, Gilman RH et al. Microscopic-observation drugsusceptibility assay for the diagnosis of TB. N Engl J Med 2006; 355: 1539-550.
10. Minion J, Leung E, Menzies D et al. Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2010; 10: 688-98.
11. Shah NS, Moodley P, Babaria P et al. Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay. Am J Respir Crit Care Med 2011; 183: 1427-33.
12. Makamure B, Mhaka J, Makumbirofa S et al. Microscopic-observation drug-susceptibility assay for the diagnosis of drug-resistant tuberculosis in Harare, Zimbabwe. PLoS One 2013; 8: e55872.
13. WHO. Noncommercial Culture and Drug-Susceptibility Testing Methods for Screening Patients at Risk for Multidrug-Resistant Tuberculosis: Policy Statement. Geneva, Switzerland, 2011. http:// whqlibdoc.who.int/publications/2011/9789241501620_eng.pdf.
14. Huang ZK, Luo Q, Jiang BX et al. Performance of the microscopic observation drug susceptibility assay in pyrazinamide susceptibility testing for Mycobacterium tuberculosis. Chin Med J (Engl) 2013; 126: 4334-9.
15. Huang Z, Xiong G, Luo Q et al. Evaluation of the performance of the microscopic observation drug susceptibility assay for diagnosis of extrapulmonary tuberculosis in China: a preliminary study. Respirology 2014; 19: 132-7.
16. Kent PT, Kubica GP. Public Health Mycobacteriology: A Guide for the Level III Laboratory. Atlanta, GA: US Department of Health & Human Services, 1985; 168.
17. Becton, Dickinson and Company. Becton Dickinson: Laboratory Procedure. BBLTM MGITTM Mycobacteria Growth Indicator Tube, OADC Enrichment, PANTATM Antibiotic Mixture. http://www.bd.com/ds/ technicalCenter/clsi/clsi-ManualMGIT.pdf.
18. Singh S, Kumar P, Sharma S et al. Rapid identification and drug susceptibility testing of Mycobacterium tuberculosis: standard operating procedure for non-commercial assays: part 1: microscopic observation drug susceptibility assay v2.4.12. J Lab Physicians 2012; 4: 101-11.
19. Fitzwater SP, Sechler GA, Jave O et al. Second-line anti-tuberculosis drug concentrations for susceptibility testing in the MODS assay. Eur Respir J 2013; 41: 1163-71.
20. Trollip AP, Moore D, Coronel J et al. Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay. Int J Tuberc Lung Dis 2014; 18: 227-32.
21. Martin A, Paasch F, Docx S et al. Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosis. J Antimicrob Chemother 2011; 66: 827-33.
22. Martin A, Imperiale B, Ravolonandriana P et al. Prospective multicentre evaluation of the direct nitrate reductase assay for the rapid detection of extensively drug-resistant tuberculosis. J Antimicrob Chemother 2014; 69: 441-4.
23. Kontsevaya I, Ignatyeva O, Nikolayevskyy V et al. Diagnostic accuracy of the GenoType MTBDRsl assay for rapid diagnosis of extensively drug-resistant tuberculosis in HIV-coinfected patients. J Clin Microbiol 2013; 51: 243-8.
24. Devasia RA, Blackman A, May C et al. Fluoroquinolone resistance in Mycobacterium tuberculosis: an assessment of MGIT 960, MODS and nitrate reductase assay and fluoroquinolone cross-resistance. J Antimicrob Chemother 2009; 63: 1173-8.
25. Moore DAJ, Gilman RH, Friedland JS. MODS assay for the diagnosis of TB. N Engl J Med 2007; 256: 189.